In recent years, real-time fluorescence quantitative polymerase chain reaction (qPCR) technology has become an essential tool for molecular diagnosis, pathogen detection, and gene expression analysis, thanks to its high sensitivity, speed, and real-time quantification capabilities. In 2022, the global market size of nucleic acid testing-related products and services, including instruments, reagents, consumables, and after-sales service support, reached 7.3 billion US dollars, with PCR-based technologies accounting for 66.7% of the market share and exhibiting a consistent growth trend. Although qPCR technology has been widely applied across multiple fields, the preclinical development of diagnostic kits-a process that includes primer design and reaction system optimization-still faces such issues as unclear procedures, non-standardized methods, and inconsistent evaluation criteria. Herein, we reviewed the guidelines, key resources, and standardized processes of qPCR assay reagent development, aiming to provide theoretical support for improving the efficiency and quality control of assay reagent development, and to discuss future directions for the optimizing and improving qPCR technology in the context of artificial intelligence.
{"title":"[Preclinical Development Process and Prospects of Real-time Fluorescence Quantitative Polymerase Chain Reaction Detection Kits].","authors":"Chuan Wang, Shaohe Li, Shirong Zhang","doi":"10.12182/20250960508","DOIUrl":"10.12182/20250960508","url":null,"abstract":"<p><p>In recent years, real-time fluorescence quantitative polymerase chain reaction (qPCR) technology has become an essential tool for molecular diagnosis, pathogen detection, and gene expression analysis, thanks to its high sensitivity, speed, and real-time quantification capabilities. In 2022, the global market size of nucleic acid testing-related products and services, including instruments, reagents, consumables, and after-sales service support, reached 7.3 billion US dollars, with PCR-based technologies accounting for 66.7% of the market share and exhibiting a consistent growth trend. Although qPCR technology has been widely applied across multiple fields, the preclinical development of diagnostic kits-a process that includes primer design and reaction system optimization-still faces such issues as unclear procedures, non-standardized methods, and inconsistent evaluation criteria. Herein, we reviewed the guidelines, key resources, and standardized processes of qPCR assay reagent development, aiming to provide theoretical support for improving the efficiency and quality control of assay reagent development, and to discuss future directions for the optimizing and improving qPCR technology in the context of artificial intelligence.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1177-1183"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709066/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Objective: </strong>Cheng's Juanbi Decoction (CSJBD) is a classic traditional Chinese medicine formula for treating rheumatoid arthritis (RA), exhibiting significant clinical efficacy, but the underlying mechanisms remain unclear. We investigated whether CSJBD inhibited RA pathology by blocking the WTAP-Wnt7b-Wnt/β-catenin signaling axis using a collagen-induced arthritis (CIA) mouse model and fibroblast-like synoviocytes (FLSs) derived from RA patients (RA FLSs) and examined the underlying mechanisms.</p><p><strong>Methods: </strong>We conducted <i>in vivo</i> experiments. Male C57BL/6 mice weighing 17 to 20 g were used to establish the CIA model. The mice were assigned to 6 groups, including the normal group, the model (CIA) group, the model + CSJBD-L (8.1 g/kg) group, the model + CSJBD-M (16.2 g/kg) group, the model + CSJBD-H (32.4 g/kg) group, and the model + leflunomide (LEF) (0.05 mg/10 g) group, with 10 mice in each group. CSJBD was administered twice daily via gastric gavage, while LEF was administered once daily via gastric gavage, for a duration of 28 days. We also conducted <i>in vitro</i> experiments. RA FLSs were assigned to 4 groups, including the RA FLSs + CSJBDS-L group receiving 10% CSJBDS-containing serum, the RA FLSs + CSJBDS-M group receiving 15% CSJBDS-containing serum, the RA FLSs + CSJBDS-H group receiving 20% CSJBDS-containing serum, and the RA FLSs + NC group (negative control). To study whether WTAP regulated Wnt7b, RA FLSs were divided into the RA FLSs group, the RA FLSs + si-<i>WTAP</i>#3 group, the RA FLSs + si-<i>WTAP</i>#3 + Wnt7b-OE group, and the RA FLSs + si-<i>WTAP</i>#3 + Wnt7b-NC group. To study the underlying mechanism by which CSJBT affected RA FLSs, RA FLSs were divided into the RA FLSs group, the RA FLSs + CSJBDS-M group, the RA FLSs+CSJBDS-M + Wnt7b-OE group, and the RA FLSs+CSJBDS-M + NC group. We used ultra-high performance liquid chromatography (UPLC) to identify and quantify key monomer compounds from CSJBD as quality criteria for CSJBD preparation. Bioinformatics, CCK-8, RT-qPCR, Western blot, immunofluorescence, and related methods were employed to assess the therapeutic efficacy and underlying mechanisms of CSJBD in treating RA.</p><p><strong>Results: </strong>According to the UPLC analysis, ferulic acid, osthole, mulberroside A, notopterol, and gentiopicroside were identified as quality control standards for the preparation of CSJBD formula. CSJBD improved RA pathology in CIA mice, reduced the levels of interleukin (IL)-6, IL-1β, IL-8, and tumor necrosis factor-α (TNF-α) in their serum, and decreased the expression of RA pathological genes <i>MMP3</i> and fibronectin, with the difference between groups being statistically significant. Bioinformatics analysis suggested that CSJBD might inhibit RA pathology by suppressing the Wnt/β-catenin signaling pathway through Wnt7b. Experimental results showed that the expression of WTAP and Wnt7b was significantly increased in RA. After knocking do
{"title":"[Cheng's Juanbi Decoction Inhibits Rheumatoid Arthritis Pathology by Blocking the WTAP-Wnt7b-Wnt/β-Catenin Signaling Axis].","authors":"Yajie Wu, Wenbo Xu, Meiling Yuan, Xinyue Zhou, Yikang Cai, Huibo Cao, Qiangjun Duan, Tongxiang Tao, Chenggui Miao","doi":"10.12182/20250960106","DOIUrl":"10.12182/20250960106","url":null,"abstract":"<p><strong>Objective: </strong>Cheng's Juanbi Decoction (CSJBD) is a classic traditional Chinese medicine formula for treating rheumatoid arthritis (RA), exhibiting significant clinical efficacy, but the underlying mechanisms remain unclear. We investigated whether CSJBD inhibited RA pathology by blocking the WTAP-Wnt7b-Wnt/β-catenin signaling axis using a collagen-induced arthritis (CIA) mouse model and fibroblast-like synoviocytes (FLSs) derived from RA patients (RA FLSs) and examined the underlying mechanisms.</p><p><strong>Methods: </strong>We conducted <i>in vivo</i> experiments. Male C57BL/6 mice weighing 17 to 20 g were used to establish the CIA model. The mice were assigned to 6 groups, including the normal group, the model (CIA) group, the model + CSJBD-L (8.1 g/kg) group, the model + CSJBD-M (16.2 g/kg) group, the model + CSJBD-H (32.4 g/kg) group, and the model + leflunomide (LEF) (0.05 mg/10 g) group, with 10 mice in each group. CSJBD was administered twice daily via gastric gavage, while LEF was administered once daily via gastric gavage, for a duration of 28 days. We also conducted <i>in vitro</i> experiments. RA FLSs were assigned to 4 groups, including the RA FLSs + CSJBDS-L group receiving 10% CSJBDS-containing serum, the RA FLSs + CSJBDS-M group receiving 15% CSJBDS-containing serum, the RA FLSs + CSJBDS-H group receiving 20% CSJBDS-containing serum, and the RA FLSs + NC group (negative control). To study whether WTAP regulated Wnt7b, RA FLSs were divided into the RA FLSs group, the RA FLSs + si-<i>WTAP</i>#3 group, the RA FLSs + si-<i>WTAP</i>#3 + Wnt7b-OE group, and the RA FLSs + si-<i>WTAP</i>#3 + Wnt7b-NC group. To study the underlying mechanism by which CSJBT affected RA FLSs, RA FLSs were divided into the RA FLSs group, the RA FLSs + CSJBDS-M group, the RA FLSs+CSJBDS-M + Wnt7b-OE group, and the RA FLSs+CSJBDS-M + NC group. We used ultra-high performance liquid chromatography (UPLC) to identify and quantify key monomer compounds from CSJBD as quality criteria for CSJBD preparation. Bioinformatics, CCK-8, RT-qPCR, Western blot, immunofluorescence, and related methods were employed to assess the therapeutic efficacy and underlying mechanisms of CSJBD in treating RA.</p><p><strong>Results: </strong>According to the UPLC analysis, ferulic acid, osthole, mulberroside A, notopterol, and gentiopicroside were identified as quality control standards for the preparation of CSJBD formula. CSJBD improved RA pathology in CIA mice, reduced the levels of interleukin (IL)-6, IL-1β, IL-8, and tumor necrosis factor-α (TNF-α) in their serum, and decreased the expression of RA pathological genes <i>MMP3</i> and fibronectin, with the difference between groups being statistically significant. Bioinformatics analysis suggested that CSJBD might inhibit RA pathology by suppressing the Wnt/β-catenin signaling pathway through Wnt7b. Experimental results showed that the expression of WTAP and Wnt7b was significantly increased in RA. After knocking do","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1260-1272"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12712374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chikungunya fever is an infectious disease caused by the Chikungunya virus (CHIKV), an arbovirus. In recent years, large-scale outbreaks of Chikungunya fever have occurred in many parts of the world, posing a serious challenge to public health. Perinatal infection of CHIKV and its impact on neonates have attracted growing attention. This article aims to introduce the mechanisms and the influencing factors of mother-to-child transmission of CHIKV and to explore its impact on the nervous system in neonates. According to reported findings, CHIKV can cross the placental barrier, causing infection in the fetus, and can cross the blood-brain barrier, leading to various neurological diseases in neonates, such as microcephaly and encephalitis. In addition, factors influencing mother-to-child transmission include the maternal viral load and the stage of pregnancy at the time of infection. Through a review of current scholarly works, this article provides ideas and a theoretical basis for the prevention and control of mother-to-child transmission of CHIKV and for research into the mechanisms underlying CHIKV-induced brain injury in neonates.
{"title":"[Mother-to-Child Transmission of Chikungunya Virus and Its Impact on the Neonatal Nervous System].","authors":"Keren Luo, Jun Tang","doi":"10.12182/20250960201","DOIUrl":"10.12182/20250960201","url":null,"abstract":"<p><p>Chikungunya fever is an infectious disease caused by the Chikungunya virus (CHIKV), an arbovirus. In recent years, large-scale outbreaks of Chikungunya fever have occurred in many parts of the world, posing a serious challenge to public health. Perinatal infection of CHIKV and its impact on neonates have attracted growing attention. This article aims to introduce the mechanisms and the influencing factors of mother-to-child transmission of CHIKV and to explore its impact on the nervous system in neonates. According to reported findings, CHIKV can cross the placental barrier, causing infection in the fetus, and can cross the blood-brain barrier, leading to various neurological diseases in neonates, such as microcephaly and encephalitis. In addition, factors influencing mother-to-child transmission include the maternal viral load and the stage of pregnancy at the time of infection. Through a review of current scholarly works, this article provides ideas and a theoretical basis for the prevention and control of mother-to-child transmission of CHIKV and for research into the mechanisms underlying CHIKV-induced brain injury in neonates.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1427-1433"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145782765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jiajie Cai, Ning Zhang, Yi Xiang, Hongmei Zhang, Xiong Xiao
Objective: To investigate the association between healthy lifestyle factors and cardiovascular biological aging, as well as the relative contributions of different lifestyle factors.
Methods: Based on the clinical biochemical data and anthropometric data from the baseline survey of the UK Biobank (UKB), the Klemera-Doubal method (KDM) was used to establish cardiovascular biological age (CBA), and CBA acceleration was calculated accordingly. Multiple linear regression models were used to estimate the associations between healthy lifestyle factors and CBA acceleration. Then, the Quantile g-computation (QGC) was applied to evaluate the relative contributions of different lifestyle factors to CBA acceleration, with further analyses conducted separately for male and female populations. Additionally, stratified analyses were performed based on age, sex, body mass index (BMI), racial background, and family history of cardiovascular diseases to examine population heterogeneity.
Results: A total of 251478 participants were included in the study. Both the overall healthy lifestyle score and each of the 7 lifestyle factors were negatively associated with CBA acceleration (overall lifestyle score: β = -0.75, 95% CI: -0.77 to -0.73). Regarding the relative contributions of different lifestyle factors, alcohol consumption and diet accounted for the highest proportions (25.8% and 25.7%, respectively). However, there were differences by sex-alcohol consumption contributed the most in men (29.5%), followed by diet (23.0%), while in women, diet contributed the most (34.5%) and alcohol consumption accounted for a relatively low proportion (5.5%). Stratified analyses suggested that sex, BMI, and race might be potential effect modifiers.
Conclusion: Lifestyle factors, as modifiable behaviors, can slow the rate of cardiovascular biological aging. Among these factors, alcohol consumption and diet may represent effective targets for intervention.
{"title":"[Effects of Multiple Lifestyle Factors on Cardiovascular Biological Aging and Their Relative Contributions].","authors":"Jiajie Cai, Ning Zhang, Yi Xiang, Hongmei Zhang, Xiong Xiao","doi":"10.12182/20250960608","DOIUrl":"10.12182/20250960608","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the association between healthy lifestyle factors and cardiovascular biological aging, as well as the relative contributions of different lifestyle factors.</p><p><strong>Methods: </strong>Based on the clinical biochemical data and anthropometric data from the baseline survey of the UK Biobank (UKB), the Klemera-Doubal method (KDM) was used to establish cardiovascular biological age (CBA), and CBA acceleration was calculated accordingly. Multiple linear regression models were used to estimate the associations between healthy lifestyle factors and CBA acceleration. Then, the Quantile g-computation (QGC) was applied to evaluate the relative contributions of different lifestyle factors to CBA acceleration, with further analyses conducted separately for male and female populations. Additionally, stratified analyses were performed based on age, sex, body mass index (BMI), racial background, and family history of cardiovascular diseases to examine population heterogeneity.</p><p><strong>Results: </strong>A total of 251478 participants were included in the study. Both the overall healthy lifestyle score and each of the 7 lifestyle factors were negatively associated with CBA acceleration (overall lifestyle score: <i>β</i> = -0.75, 95% CI: -0.77 to -0.73). Regarding the relative contributions of different lifestyle factors, alcohol consumption and diet accounted for the highest proportions (25.8% and 25.7%, respectively). However, there were differences by sex-alcohol consumption contributed the most in men (29.5%), followed by diet (23.0%), while in women, diet contributed the most (34.5%) and alcohol consumption accounted for a relatively low proportion (5.5%). Stratified analyses suggested that sex, BMI, and race might be potential effect modifiers.</p><p><strong>Conclusion: </strong>Lifestyle factors, as modifiable behaviors, can slow the rate of cardiovascular biological aging. Among these factors, alcohol consumption and diet may represent effective targets for intervention.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1357-1364"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709100/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Donghui Ke, Xingyan Tan, Kun Chen, Xu Xue, Ni An, Kerui Ye, Xiaorui Zhang, Yuqing Li, Jumei Zeng
The elimination of biofilms is a crucial step in controlling hospital-acquired infections. Once biofilms colonize luminal instruments, it is difficult to remove them using traditional disinfection methods. Conventional disinfection approaches now face a series of challenges, including microbial resistance, corrosiveness, cytotoxicity, residual disinfection byproducts, and environmental pollution. Therefore, developing novel disinfection technologies specifically targeting biofilm removal is vitally important. New disinfection technologies, such as slightly acidic electrolyzed water, plasma technology, surface modification techniques, nanomaterial-based disinfection, bacteriophage disinfection, and enzymatic disinfection, are constantly emerging. These technologies exhibit excellent performance against biofilms by leveraging the synergistic effects of multiple mechanisms, including the reactive oxygen species (ROS) burst, photocatalytic oxidation, physical disruption, and biological targeting. This review summarizes the characteristics, underlying mechanisms, and potential application scenarios of these novel disinfection technologies, with a particular focus on their effects against biofilms formed by common pathogenic bacteria on surfaces in hospital settings. It aims to provide a reference basis for the practical application and translation of these disinfection technologies and the development of new disinfection strategies.
{"title":"[Advances in Novel Disinfection Technologies for Biofilm-Associated Nosocomial Infections].","authors":"Donghui Ke, Xingyan Tan, Kun Chen, Xu Xue, Ni An, Kerui Ye, Xiaorui Zhang, Yuqing Li, Jumei Zeng","doi":"10.12182/20250960203","DOIUrl":"10.12182/20250960203","url":null,"abstract":"<p><p>The elimination of biofilms is a crucial step in controlling hospital-acquired infections. Once biofilms colonize luminal instruments, it is difficult to remove them using traditional disinfection methods. Conventional disinfection approaches now face a series of challenges, including microbial resistance, corrosiveness, cytotoxicity, residual disinfection byproducts, and environmental pollution. Therefore, developing novel disinfection technologies specifically targeting biofilm removal is vitally important. New disinfection technologies, such as slightly acidic electrolyzed water, plasma technology, surface modification techniques, nanomaterial-based disinfection, bacteriophage disinfection, and enzymatic disinfection, are constantly emerging. These technologies exhibit excellent performance against biofilms by leveraging the synergistic effects of multiple mechanisms, including the reactive oxygen species (ROS) burst, photocatalytic oxidation, physical disruption, and biological targeting. This review summarizes the characteristics, underlying mechanisms, and potential application scenarios of these novel disinfection technologies, with a particular focus on their effects against biofilms formed by common pathogenic bacteria on surfaces in hospital settings. It aims to provide a reference basis for the practical application and translation of these disinfection technologies and the development of new disinfection strategies.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1243-1250"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709068/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Wanlin He, Hailong Li, Jinli Meng, Li Feng, Zan Zhou, Yonghong Huang, Kejin Xiang, Hengyan Li, Xiaomei Li, Yuanyuan He, Xiaoyan Luo, Lu Che, Xiaoqi Huang
<p><strong>Objective: </strong>To analyze changes in sleep, mood state, and brain function in healthy populations living in near-sea-level environments before and after exposure to high-altitude environment, and to explore the correlations between regional brain functional changes and variations in sleep and mood states.</p><p><strong>Methods: </strong>A total of 45 healthy volunteers were enrolled. The participants came from regions of near-sea-level altitudes and were exposed to the high-altitude environment for a short period of time. The Pittsburgh Sleep Quality Index (PSQI), Zung Self-Rating Depression Scale (SDS), Patient Health Questionnaire-9 (PHQ-9), Zung Self-Rating Anxiety Scale (SAS), and Generalized Anxiety Disorder-7 (GAD-7) were administered to assess sleep quality as well as depressive and anxiety symptoms at 4 time points-prior to high-altitude exposure, immediately after exposure, one month after returning to low-altitude regions, and three months after returning to low-altitude regions. Resting-state functional magnetic resonance imaging (rs-fMRI) data were collected before and after high-altitude exposure, and regional brain functional parameters, including the amplitude of low-frequency fluctuations (ALFF) and functional connectivity strength, were analyzed. Statistical analyses were performed, including a linear mixed-effects model to evaluate longitudinal changes in scale scores, paired-sample <i>t</i>-tests to compare brain function differences before and after exposure, and Pearson correlation analyses to examine the relationship between brain functional changes and alterations in sleep and mood states.</p><p><strong>Results: </strong>Compared with the pre-exposure findings, the participants exhibited significantly increased PSQI scores (8.89 ± 4.41 vs. 5.08 ± 2.69, <i>P</i> < 0.05) and PHQ-9 scores (3.60 ± 4.19 vs.1.54 ± 2.30, <i>P</i> < 0.05) immediately after high-altitude exposure. One month after returning to the low-altitude environment, both sleep and depression scores decreased relative to the findings immediately after exposure (PSQI: 3.88 ± 2.13 vs. 8.89 ± 4.41, <i>P</i> < 0.05; PHQ-9: 1.50 ± 2.25 vs. 3.60 ± 4.19, <i>P</i> < 0.05) and showed no statistically significant difference compared with the pre-exposure findings (<i>P</i> > 0.05). Three months after returning to near-sea-level environment, sleep, depression, and anxiety scores were all reduced compared with the findings immediately after exposure (PSQI: 3.76 ± 2.31 vs. 8.89 ± 4.41, <i>P</i> < 0.05; PHQ-9: 1.24 ± 2.13 vs. 3.60 ± 4.19, <i>P</i> < 0.05; SAS: 23.84 ± 5.93 vs. 27.93 ± 7.05, <i>P</i> < 0.05), also showing no significant difference compared with the pre-exposure levels (<i>P</i> > 0.05). Brain function analysis revealed that, relative to the pre-exposure levels, ALFF in the bilateral superior temporal gyrus, insula, and dorsolateral prefrontal cortex (DLPFC) increased after high-altitude exposure (<i>P</i> < 0.05), and that functional connectiv
{"title":"[Dynamic Effects of High-Altitude Exposure on Sleep and Mood States and the Underlying Neural Mechanisms].","authors":"Wanlin He, Hailong Li, Jinli Meng, Li Feng, Zan Zhou, Yonghong Huang, Kejin Xiang, Hengyan Li, Xiaomei Li, Yuanyuan He, Xiaoyan Luo, Lu Che, Xiaoqi Huang","doi":"10.12182/20250960507","DOIUrl":"10.12182/20250960507","url":null,"abstract":"<p><strong>Objective: </strong>To analyze changes in sleep, mood state, and brain function in healthy populations living in near-sea-level environments before and after exposure to high-altitude environment, and to explore the correlations between regional brain functional changes and variations in sleep and mood states.</p><p><strong>Methods: </strong>A total of 45 healthy volunteers were enrolled. The participants came from regions of near-sea-level altitudes and were exposed to the high-altitude environment for a short period of time. The Pittsburgh Sleep Quality Index (PSQI), Zung Self-Rating Depression Scale (SDS), Patient Health Questionnaire-9 (PHQ-9), Zung Self-Rating Anxiety Scale (SAS), and Generalized Anxiety Disorder-7 (GAD-7) were administered to assess sleep quality as well as depressive and anxiety symptoms at 4 time points-prior to high-altitude exposure, immediately after exposure, one month after returning to low-altitude regions, and three months after returning to low-altitude regions. Resting-state functional magnetic resonance imaging (rs-fMRI) data were collected before and after high-altitude exposure, and regional brain functional parameters, including the amplitude of low-frequency fluctuations (ALFF) and functional connectivity strength, were analyzed. Statistical analyses were performed, including a linear mixed-effects model to evaluate longitudinal changes in scale scores, paired-sample <i>t</i>-tests to compare brain function differences before and after exposure, and Pearson correlation analyses to examine the relationship between brain functional changes and alterations in sleep and mood states.</p><p><strong>Results: </strong>Compared with the pre-exposure findings, the participants exhibited significantly increased PSQI scores (8.89 ± 4.41 vs. 5.08 ± 2.69, <i>P</i> < 0.05) and PHQ-9 scores (3.60 ± 4.19 vs.1.54 ± 2.30, <i>P</i> < 0.05) immediately after high-altitude exposure. One month after returning to the low-altitude environment, both sleep and depression scores decreased relative to the findings immediately after exposure (PSQI: 3.88 ± 2.13 vs. 8.89 ± 4.41, <i>P</i> < 0.05; PHQ-9: 1.50 ± 2.25 vs. 3.60 ± 4.19, <i>P</i> < 0.05) and showed no statistically significant difference compared with the pre-exposure findings (<i>P</i> > 0.05). Three months after returning to near-sea-level environment, sleep, depression, and anxiety scores were all reduced compared with the findings immediately after exposure (PSQI: 3.76 ± 2.31 vs. 8.89 ± 4.41, <i>P</i> < 0.05; PHQ-9: 1.24 ± 2.13 vs. 3.60 ± 4.19, <i>P</i> < 0.05; SAS: 23.84 ± 5.93 vs. 27.93 ± 7.05, <i>P</i> < 0.05), also showing no significant difference compared with the pre-exposure levels (<i>P</i> > 0.05). Brain function analysis revealed that, relative to the pre-exposure levels, ALFF in the bilateral superior temporal gyrus, insula, and dorsolateral prefrontal cortex (DLPFC) increased after high-altitude exposure (<i>P</i> < 0.05), and that functional connectiv","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1313-1319"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709070/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To analyze the risk factors associated with central nervous system (CNS) infection in patients after neuroendoscopic hematoma removal combined with and microscopic hematoma removal, and to construct and validate a nomogram prediction model.
Methods: A total of 460 patients who underwent neuroendoscopic hematoma removal combined with microscopic hematoma removal at our hospital between January 2021 and December 2024 were retrospectively enrolled. The patients were assigned to a modeling cohort (n = 322) and a validation cohort (n = 138) in a 7∶3 ratio. Furthermore, the modeling cohort was divided into an infection group (n = 68) and a non-infected group (n = 254) according to whether CNS infection occurred. The independent predictors of central nervous system infection were identified by logistic regression analysis, and a nomogram prediction model was constructed accordingly.
Results: The overall incidence of CNS infection in the 460 patients was 20.65% (95/460). According to the logistic regression analysis, the independent risk factors for CNS infection in patients after neuroendoscopic and microscopic combined hematoma removal included a history of diabetes mellitus (odds ratio [OR] = 3.431, 95% CI: 1.300-9.057), the Glasgow Coma Scale (GCS) score (OR = 0.574, 95% CI: 0.462-0.711), cerebrospinal fluid leakage (OR = 4.492, 95% CI: 1.430-14.116), operation duration (OR = 1.011, 95% CI: 1.004-1.019), duration of drainage tube placement (OR = 5.452, 95% CI: 2.423-12.268) and albumin (ALB) level (OR = 0.778, 95% CI: 0.720-0.840) (P < 0.05). Based on these risk factors, a nomogram prediction model was constructed, and the area under the receiver operating characteristic curve (AUC) of the predicted events in the modeling cohort and the validation cohort was 0.928 (95% CI: 0.895-0.960) and 0.918 (95% CI: 0.885-0.951), respectively. The calibration curve fitted well with the ideal curve (Hosmer-Lemeshow test, P > 0.05), and the decision curve analysis demonstrated significant net benefit.
Conclusion: The nomogram model based on history of diabetes mellitus, GCS score, cerebrospinal fluid leakage, operation duration, duration of drainage tube placement, and ALB level demonstrates high predictive performance for CNS infection after neuroendoscopy-assisted microscopic hematoma removal.
{"title":"[Central Nervous System Infection After Neuroendoscopic and Microscopic Combined Hematoma Removal: Risk Factors and Construction of a Nomogram Prediction Model].","authors":"Dan Liang, Kun Zhou, Bo Shu","doi":"10.12182/20250960607","DOIUrl":"10.12182/20250960607","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the risk factors associated with central nervous system (CNS) infection in patients after neuroendoscopic hematoma removal combined with and microscopic hematoma removal, and to construct and validate a nomogram prediction model.</p><p><strong>Methods: </strong>A total of 460 patients who underwent neuroendoscopic hematoma removal combined with microscopic hematoma removal at our hospital between January 2021 and December 2024 were retrospectively enrolled. The patients were assigned to a modeling cohort (<i>n</i> = 322) and a validation cohort (<i>n</i> = 138) in a 7∶3 ratio. Furthermore, the modeling cohort was divided into an infection group (<i>n</i> = 68) and a non-infected group (<i>n</i> = 254) according to whether CNS infection occurred. The independent predictors of central nervous system infection were identified by logistic regression analysis, and a nomogram prediction model was constructed accordingly.</p><p><strong>Results: </strong>The overall incidence of CNS infection in the 460 patients was 20.65% (95/460). According to the logistic regression analysis, the independent risk factors for CNS infection in patients after neuroendoscopic and microscopic combined hematoma removal included a history of diabetes mellitus (odds ratio [OR] = 3.431, 95% CI: 1.300-9.057), the Glasgow Coma Scale (GCS) score (OR = 0.574, 95% CI: 0.462-0.711), cerebrospinal fluid leakage (OR = 4.492, 95% CI: 1.430-14.116), operation duration (OR = 1.011, 95% CI: 1.004-1.019), duration of drainage tube placement (OR = 5.452, 95% CI: 2.423-12.268) and albumin (ALB) level (OR = 0.778, 95% CI: 0.720-0.840) (<i>P</i> < 0.05). Based on these risk factors, a nomogram prediction model was constructed, and the area under the receiver operating characteristic curve (AUC) of the predicted events in the modeling cohort and the validation cohort was 0.928 (95% CI: 0.895-0.960) and 0.918 (95% CI: 0.885-0.951), respectively. The calibration curve fitted well with the ideal curve (Hosmer-Lemeshow test, <i>P</i> > 0.05), and the decision curve analysis demonstrated significant net benefit.</p><p><strong>Conclusion: </strong>The nomogram model based on history of diabetes mellitus, GCS score, cerebrospinal fluid leakage, operation duration, duration of drainage tube placement, and ALB level demonstrates high predictive performance for CNS infection after neuroendoscopy-assisted microscopic hematoma removal.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1296-1304"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709062/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Weiyang Sun, Yujing Chuai, Xiaotao Zhou, Tianai Zhang, Li Yong, Lin Ren, Xinyue Luo, Xiaoli Zou
<p><strong>Objective: </strong>To establish an analytical method for the simultaneous determination of 18 perfluoroalkyl compounds (PFCs) in tea leaves using a quick, easy, cheap, effective, rugged, and safe (QuEChERS) method for sample pretreatment combined with ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).</p><p><strong>Methods: </strong>The target analytes-18 PFCs-included 13 carboxylic acid PFCs (perfluorobutanoic acid [PFBA], perfluoropentanoic acid [PFPeA], perfluorohexanoic acid [PFHxA], perfluoroheptanoic acid [PFHpA], perfluorooctanoic acid [PFOA], perfluorononanoic acid [PFNA], perfluorodecanoic acid [PFDA], perfluoroundecanoic acid [PFUdA], perfluorododecanoic acid [PFTrDA], perfluorotridecanoic acid [PFTeDA], perfluorotetradecanoic acid [PFHxDA], perfluorohexadecanoic acid [PFHpS], and perfluorooctadecanoic acid [PFODA]) and 5 sulfonic acid PFCs (perfluorobutanesulfonic acid [PFBS], perfluorohexanesulfonic acid [PFHxS], perfluoroheptanesulfonic acid [PFHpS], perfluorooctanesulfonic acid [PFOS], and perfluorodecanesulfonic acid [PFDS]). The QuEChERS pretreatment parameters were systematically optimized using the response surface methodology. The tea leave samples were extracted with an 80% acetonitrile solution and subsequently purified by adding a mixed absorbent consisting of 20 mg N-propyl-ethylenediamine (PSA), 210 mg graphitized carbon black GCB), and 60 mg octadecylsilane (C<sub>18</sub>). The supernatant was concentrated by nitrogen blowing and subsequently re-dissolved in 50% methanol-2 mmol/L ammonium acetate solution. The re-dissolved solution was injected into the UHPLC-MS/MS for analysis. The target analytes were separated on an ACQUITY UPLC BEH C<sub>18</sub> column (2.1 mm × 50 mm, 1.7 µm). The mobile phases consisted of methanol (phase A) and 2 mmol/L aqueous ammonium acetate (phase B), with a gradient elution procedure. The total running time was 18 min. The mass spectrometry analysis was conducted using an electrospray ionization source in negative ionization mode and multi-reaction monitoring (MRM), with quantification performed using the internal standard curve method. The greenness of the analytical method was assessed using Analytical GREEnness calculator (AGREE) and the Analytical Eco-Scale method (AES).</p><p><strong>Results: </strong>Under the optimized conditions, the limits of detection (LODs) and limits of quantification (LOQs) of the method were 0.0057-1.23 ng/g and 0.019-4.09 ng/g, respectively. The average recoveries of most target compounds were 71.1%-117.9%, with relative standard deviations (RSDs) below 15%. The AGREE index of the method was 0.49, and the AES score was 76. At least one PFC was detected in each of the 132 tea leave samples, and the detection rate of carboxylic acid PFC was higher than that of sulfonic acid PFC. The highest detection rates were observed for PFBA at 97.74%, PFHpA at 93.23%, and PFOA at 92.24%. In contrast, PFHpS, PFUdA, PFDoA, PFHxDA, and P
目的:建立快速、简便、廉价、有效、坚固、安全的QuEChERS样品前处理联合超高效液相色谱-串联质谱(UPLC-MS/MS)同时测定茶叶中18种全氟烷基化合物(PFCs)的分析方法。方法:目标分析物-18种全氟碳化物-包括13种羧酸型全氟碳化物(全氟丁酸[PFBA]、全氟戊酸[PFPeA]、全氟己酸[PFHxA]、全氟庚酸[PFHpA]、全氟辛酸[PFOA]、全氟壬酸[PFNA]、全氟癸酸[PFDA]、全氟癸酸[PFUdA]、全氟十二烷酸[PFTrDA]、全氟三十一烷酸[PFTeDA]、全氟十四烷酸[PFHxDA]、全氟十六烷酸[PFHpS]、以及全氟十二烷酸[PFODA])和5种磺酸全氟碳化合物(全氟丁烷磺酸[PFBS]、全氟己磺酸[PFHxS]、全氟庚烷磺酸[PFHpS]、全氟辛烷磺酸[PFOS]和全氟十烷磺酸[PFDS])。采用响应面法对QuEChERS预处理参数进行了系统优化。用80%乙腈溶液提取茶叶样品,然后加入由20 mg n -丙基-乙二胺(PSA)、210 mg石墨化炭黑(GCB)和60 mg十八烷基硅烷(C18)组成的混合吸附剂进行纯化。上清液经吹氮浓缩后再溶解于50%甲醇-2 mmol/L乙酸铵溶液中。再溶液注入UHPLC-MS/MS进行分析。目标分析物在ACQUITY UPLC BEH C18色谱柱(2.1 mm × 50 mm, 1.7µm)上分离。流动相为甲醇(A相)和2 mmol/L醋酸铵(B相),采用梯度洗脱法。总运行时间为18分钟。质谱分析采用负电离模式电喷雾电离源和多反应监测(MRM),定量采用内标曲线法。采用分析绿色度计算器(AGREE)和分析生态尺度法(AES)对分析方法的绿色度进行评价。结果:在优化条件下,方法的检出限和定量限分别为0.0057 ~ 1.23 ng/g和0.019 ~ 4.09 ng/g。多数目标化合物的平均加样回收率为71.1% ~ 117.9%,相对标准偏差(rsd)在15%以下。该方法的AGREE指数为0.49,AES评分为76。132份茶叶样品中至少检出1种PFC,羧酸PFC检出率高于磺酸PFC,其中PFBA检出率最高,为97.74%,PFHpA检出率最高,为93.23%,PFOA检出率最高,为92.24%。而PFHpS、PFUdA、PFDoA、PFHxDA、PFODA均未检出。结论:该方法简便、快速、灵敏,适用于茶叶中全氟化合物的分析。该方法绿色度高,对操作者和环境的影响最小。市场上销售的茶叶中普遍存在PFC污染,需要加强监测和监管。
{"title":"[Determination of 18 Perfluorinated Compounds in Tea Leaves by a Quick, Easy, Cheap, Effective, Rugged, and Safe Method Combined With Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry].","authors":"Weiyang Sun, Yujing Chuai, Xiaotao Zhou, Tianai Zhang, Li Yong, Lin Ren, Xinyue Luo, Xiaoli Zou","doi":"10.12182/20250960603","DOIUrl":"10.12182/20250960603","url":null,"abstract":"<p><strong>Objective: </strong>To establish an analytical method for the simultaneous determination of 18 perfluoroalkyl compounds (PFCs) in tea leaves using a quick, easy, cheap, effective, rugged, and safe (QuEChERS) method for sample pretreatment combined with ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).</p><p><strong>Methods: </strong>The target analytes-18 PFCs-included 13 carboxylic acid PFCs (perfluorobutanoic acid [PFBA], perfluoropentanoic acid [PFPeA], perfluorohexanoic acid [PFHxA], perfluoroheptanoic acid [PFHpA], perfluorooctanoic acid [PFOA], perfluorononanoic acid [PFNA], perfluorodecanoic acid [PFDA], perfluoroundecanoic acid [PFUdA], perfluorododecanoic acid [PFTrDA], perfluorotridecanoic acid [PFTeDA], perfluorotetradecanoic acid [PFHxDA], perfluorohexadecanoic acid [PFHpS], and perfluorooctadecanoic acid [PFODA]) and 5 sulfonic acid PFCs (perfluorobutanesulfonic acid [PFBS], perfluorohexanesulfonic acid [PFHxS], perfluoroheptanesulfonic acid [PFHpS], perfluorooctanesulfonic acid [PFOS], and perfluorodecanesulfonic acid [PFDS]). The QuEChERS pretreatment parameters were systematically optimized using the response surface methodology. The tea leave samples were extracted with an 80% acetonitrile solution and subsequently purified by adding a mixed absorbent consisting of 20 mg N-propyl-ethylenediamine (PSA), 210 mg graphitized carbon black GCB), and 60 mg octadecylsilane (C<sub>18</sub>). The supernatant was concentrated by nitrogen blowing and subsequently re-dissolved in 50% methanol-2 mmol/L ammonium acetate solution. The re-dissolved solution was injected into the UHPLC-MS/MS for analysis. The target analytes were separated on an ACQUITY UPLC BEH C<sub>18</sub> column (2.1 mm × 50 mm, 1.7 µm). The mobile phases consisted of methanol (phase A) and 2 mmol/L aqueous ammonium acetate (phase B), with a gradient elution procedure. The total running time was 18 min. The mass spectrometry analysis was conducted using an electrospray ionization source in negative ionization mode and multi-reaction monitoring (MRM), with quantification performed using the internal standard curve method. The greenness of the analytical method was assessed using Analytical GREEnness calculator (AGREE) and the Analytical Eco-Scale method (AES).</p><p><strong>Results: </strong>Under the optimized conditions, the limits of detection (LODs) and limits of quantification (LOQs) of the method were 0.0057-1.23 ng/g and 0.019-4.09 ng/g, respectively. The average recoveries of most target compounds were 71.1%-117.9%, with relative standard deviations (RSDs) below 15%. The AGREE index of the method was 0.49, and the AES score was 76. At least one PFC was detected in each of the 132 tea leave samples, and the detection rate of carboxylic acid PFC was higher than that of sulfonic acid PFC. The highest detection rates were observed for PFBA at 97.74%, PFHpA at 93.23%, and PFOA at 92.24%. In contrast, PFHpS, PFUdA, PFDoA, PFHxDA, and P","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1215-1225"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709069/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Food safety problems caused by foodborne pathogenic bacteria pose a serious threat to public health, creating an urgent need to develop testing methods and techniques with excellent performance and are simple to use and of affordable cost. Traditional testing methods, such as isolation and culture, morphological observation, biochemical identification, and serological tests, have many limitations, including complex procedures, reliance on specialized technical equipment and personnel, and long turnaround time, rendering them inadequate for meeting current and future testing demands. Therefore, it is particularly important to develop simple, rapid, and highly sensitive methods for analyzing pathogenic bacteria. The fusion of nucleic acid aptamers and nanozymes brings new ideas for the rapid testing of pathogenic bacteria. On one hand, aptamers offer specific recognition capability for target bacteria and can be combined with various nucleic acid signal amplification techniques. On the other hand, the enzyme-like catalytic activity and signal amplification effect of many nanomaterials provide a basis for highly sensitive testing. This review highlights the application potential of nanozyme‒aptamer coupling systems in the field of microbial analysis by briefly summarizing the latest research progress in the use of nanozymes combined with aptamers for the detection of foodborne pathogenic bacteria. First of all, two main approaches to conjugating nanozymes with aptamers are introduced. Then, the testing mechanisms and typical applications of nanozyme‒aptamer coupling systems for foodborne pathogenic bacteria are discussed. Finally, future development trends and existing challenges are disucssed from four perspectives, including specificity, high sensitivity, high throughput, and intelligent detection. This review aims to provide a useful reference for the fusion of nanozymes and aptamers and for the development of on-site rapid testing techniques for foodborne pathogens, and to encourage broader academic interest to further advance this promising research field.
{"title":"[Advances in Nanozyme-Aptamer Systems for the Detection of Foodborne Pathogens].","authors":"Hao Liang, Shiyu Jia, Zhou Zhan, Yujiao Cai, Xiangheng Niu","doi":"10.12182/20250960204","DOIUrl":"10.12182/20250960204","url":null,"abstract":"<p><p>Food safety problems caused by foodborne pathogenic bacteria pose a serious threat to public health, creating an urgent need to develop testing methods and techniques with excellent performance and are simple to use and of affordable cost. Traditional testing methods, such as isolation and culture, morphological observation, biochemical identification, and serological tests, have many limitations, including complex procedures, reliance on specialized technical equipment and personnel, and long turnaround time, rendering them inadequate for meeting current and future testing demands. Therefore, it is particularly important to develop simple, rapid, and highly sensitive methods for analyzing pathogenic bacteria. The fusion of nucleic acid aptamers and nanozymes brings new ideas for the rapid testing of pathogenic bacteria. On one hand, aptamers offer specific recognition capability for target bacteria and can be combined with various nucleic acid signal amplification techniques. On the other hand, the enzyme-like catalytic activity and signal amplification effect of many nanomaterials provide a basis for highly sensitive testing. This review highlights the application potential of nanozyme‒aptamer coupling systems in the field of microbial analysis by briefly summarizing the latest research progress in the use of nanozymes combined with aptamers for the detection of foodborne pathogenic bacteria. First of all, two main approaches to conjugating nanozymes with aptamers are introduced. Then, the testing mechanisms and typical applications of nanozyme‒aptamer coupling systems for foodborne pathogenic bacteria are discussed. Finally, future development trends and existing challenges are disucssed from four perspectives, including specificity, high sensitivity, high throughput, and intelligent detection. This review aims to provide a useful reference for the fusion of nanozymes and aptamers and for the development of on-site rapid testing techniques for foodborne pathogens, and to encourage broader academic interest to further advance this promising research field.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1251-1259"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709073/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A growing body of evidence indicates that the visual cortex retains a considerable degree of plasticity well into adulthood, suggesting that the visual acuity and binocular visual function of adult amblyopic patients can be improved even beyond the critical period of visual development. Currently, as novel treatment options for amblyopia, pharmacological and non-invasive methods that can enhance the plasticity of the visual cortex have not yet been widely applied in clinical practice. Therefore, it is of critical importance to investigate the underlying mechanisms of visual cortex plasticity to pave the way for the development of new therapeutic strategies for amblyopia. This paper reviews current research progress on mechanisms contributing to changes in visual cortical plasticity, including the regulation of the balance between excitatory and inhibitory neural activities, extracellular matrix remodeling, inhibitory factors associated with plasticity, and neurotrophic factors. With the continued advancement of various neuroimaging technologies, future research should aim to elucidate the precise mechanisms that control the initiation and closure of the critical period, and to clarify how the various factors involved in the regulation of visual cortical plasticity act jointly across different cell types and signaling pathways. Such investigations will provide new approaches and strategies for the treatment of amblyopia.
{"title":"[Research Progress on the Mechanisms of Visual Cortical Plasticity].","authors":"Yinmiao Dong, Longqian Liu","doi":"10.12182/20250960107","DOIUrl":"10.12182/20250960107","url":null,"abstract":"<p><p>A growing body of evidence indicates that the visual cortex retains a considerable degree of plasticity well into adulthood, suggesting that the visual acuity and binocular visual function of adult amblyopic patients can be improved even beyond the critical period of visual development. Currently, as novel treatment options for amblyopia, pharmacological and non-invasive methods that can enhance the plasticity of the visual cortex have not yet been widely applied in clinical practice. Therefore, it is of critical importance to investigate the underlying mechanisms of visual cortex plasticity to pave the way for the development of new therapeutic strategies for amblyopia. This paper reviews current research progress on mechanisms contributing to changes in visual cortical plasticity, including the regulation of the balance between excitatory and inhibitory neural activities, extracellular matrix remodeling, inhibitory factors associated with plasticity, and neurotrophic factors. With the continued advancement of various neuroimaging technologies, future research should aim to elucidate the precise mechanisms that control the initiation and closure of the critical period, and to clarify how the various factors involved in the regulation of visual cortical plasticity act jointly across different cell types and signaling pathways. Such investigations will provide new approaches and strategies for the treatment of amblyopia.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1434-1439"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709103/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}